Thrombopoietin Receptor Agonist Use in Children: Data from the Pediatric ITP Consortium of North America ICON2 Study

BACKGROUND: Data on second-line treatment options for pediatric patients with immune thrombocytopenia (ITP) are limited. Thrombopoietin receptor agonists (TPO-RA) provide a non-immunosuppressive option for children who require an increased platelet count. PROCEDURE: We performed a multi-center retro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Blood Cancer
Auteurs principaux: Neunert, Cindy, Despotovic, Jenny, Haley, Kristina, Lambert, Michele P., Nottage, Kerri, Shimano, Kristin, Bennett, Carolyn, Klaassen, Robert, Stine, Kimo, Thompson, Alexis, Pastore, Yves, Brown, Travis, Forbes, Peter W., Grace, Rachael F.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5718620/
https://ncbi.nlm.nih.gov/pubmed/27135461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26003
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires